Intrasense S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 3.79 million compared to EUR 4.19 million a year ago. Net loss was EUR 3.42 million compared to EUR 1.2 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.32 EUR | +1.27% | -2.74% | -11.11% |
Apr. 17 | Intrasense: an innovative solution for cancer monitoring | CF |
Apr. 09 | Guerbet: CE certificate for a platform | CF |
1st Jan change | Capi. | |
---|---|---|
-11.11% | 17.93M | |
+12.15% | 228B | |
+14.90% | 196B | |
+18.22% | 141B | |
+29.15% | 110B | |
+0.53% | 65.88B | |
+16.92% | 54.3B | |
+6.33% | 52.39B | |
+10.93% | 45.22B | |
+5.87% | 37.12B |
- Stock Market
- Equities
- ALINS Stock
- News Intrasense
- Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2022